FOCUS Insights & Updates From AXIS
Your go-to resource for the latest developments in market access and reimbursement. Here, AXIS – The Reimbursement Experts, share industry insights, emerging trends, and proven strategies to help you navigate the complex reimbursement landscape and stay ahead of the curve.
What’s on the menu for Early Access – A lunchtime AXIS webinar series
AXIS is launching a monthly forum to dive deeper into key UK and Ireland market access topics.
Building trust with NICE: An inside view of the market access appraisal journey
After 13 years with NICE in varied and fulfilling roles, I decided to do something I never expected to do – leave the NHS and join a consultancy firm.
No rules for the use of artificial intelligence in the evaluation of new therapies.
Call at ISPOR Europe for the formation of a collaborative working group on artificial intelligence to agree on “rules of engagement” to ensure the best standards in its use.
Building trust with NICE: Key touchpoints in the appraisal journey
As a follow-up to my previous blog “Building Trust with NICE: An Inside View of the Market Access Journey”, below is a deeper dive into some of the key engagement touchpoints mentioned in the blog.
The Use of AI Tools in a NICE Submission – Reality or Pipedream?
Brenda Dooley, Founder/CEO of AXIS Healthcare Consulting chaired a recent Life Science Access Academy webinar ‘The Use of AI Tools in a NICE Submission – Reality or Pipedream?’
NICE Appeals
After NICE publishes its final decision on whether a medicine should be recommended for use in the NHS, the following registered consultees have the chance to launch a written or oral appeal if they disagree with the recommendation
Contact us
TO MAKE REQUESTS
for further information, contact us
We’re here to help you navigate the complexities of market access and reimbursement in the UK and Ireland. Whether you have a question, need expert advice, or want to discuss a potential project, our team at AXIS Consulting is ready to assist.